Outset Medical Inc. (NASDAQ: OM) reported Q4 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $13.75 million.

“In the fourth quarter our team continued to outperform while building a solid foundation for growth through 2021 and beyond,” said Leslie Trigg, President and Chief Executive Officer. “We expanded our customer base, deepened our relationships with top health systems, and continued to deliver an exceptional Tablo home experience for patients and their caregivers. More recently, we manufactured the first Tablo consoles at our new facility in Mexico, one quarter ahead of schedule, marking a milestone achievement for a key strategic initiative.”

GUIDANCE:

Outset Medical Inc. sees Q1 2021 revenue of $21-22 million, versus the consensus of $14.8 million.

Outset Medical Inc. sees FY2021 revenue of $89-94 million, versus the consensus of $71.3 million.

For earnings history and earnings-related data on Outset Medical Inc. (OM) click here.